Find out what events are coming up on their website. Founded in 1945, AAOM offers credentialing, resources and professional community for oral medicine practitioners. She participates in data analyses that help identify the success metrics of individual journals or of larger development projects. 2020 © American Academy of Oral Medicine2150 N 107th St, Suite 205 • Seattle, WA 98133 | (206) 209-5279Privacy Policy[email protected], a change in the way your teeth fit together when you close your mouth, American Academy of Oral and Maxillofacial Pathology, American Association of Oral and Maxillofacial Surgeons, ABOM Requests Recognition as National Certifying Board, ADA Coronavirus (COVID-19) Center for Dentists, a sore, or soreness or irritation that doesn’t go away, red or white patches, or pain, tenderness, or numbness in mouth or lips, lumps, thickening tissues, rough spots, crusty or eroded areas, difficulty chewing, swallowing, speaking, or moving your jaw or tongue, a painless lump or swelling felt in the neck, sore throat, difficulty swallowing, or pain when swallowing, swelling of the tonsillar areas at the back of the mouth. Support for People With Oral and Head and Neck Cancer has more than 125 U.S. chapters where you can connect and take action, including becoming a volunteer mentor or spokesperson. Dentists are important in spreading awareness about the disease, educating their patients, and spotting such cancers at an early stage. April is Oral, Head, and Neck Cancer Awareness Month. For more information about the AGD, visit agd.org. Although many people spread the word all year long, April is National Oral, Head, and Neck Cancer Awareness Month. Head and neck cancer is more common among men than women. Induction of ER and mitochondrial stress by the alkylphosphocholine erufosine in oral squamous cell carcinoma cells, Seven-CpG-based prognostic signature coupled with gene expression predicts survival of oral squamous cell carcinoma, Sex differences in patients with high risk HPV-associated and HPV negative oropharyngeal and oral cavity squamous cell carcinomas, Surface-enhanced Raman spectroscopy of blood serum based on gold nanoparticles for the diagnosis of the oral squamous cell carcinoma, Treatment of oral cancers during pregnancy: a case-based discussion, Extracapsular extension is not a significant prognostic indicator in non-squamous cancers of the major salivary glands, Nodal disease predicts recurrence whereas other traditional factors affect survival in a cohort of South African patients with differentiated thyroid carcinoma, Predictors of circulating INTERLEUKIN-6 levels in head and neck cancer patients, Prognostic implications of the phosphatidylinositol 3-kinase/Akt signaling pathway in oral squamous cell carcinoma: overexpression of p-mTOR indicates an adverse prognosis, Relation of baseline neutrophil-to-lymphocyte ratio to survival and toxicity in head and neck cancer patients treated with (chemo-) radiation, Roles of β-catenin, TCF-4, and survivin in nasopharyngeal carcinoma: correlation with clinicopathological features and prognostic significance, Salvage radiotherapy for recurrent hypopharyngeal and laryngeal squamous cell carcinoma (SCC) after first-line treatment with surgery alone: a 10-year single-centre experience, Survival and associated factors among patients with oral squamous cell carcinoma (OSCC) in Mulago hospital, Kampala, Uganda, The effect of 2D and 3D cell cultures on treatment response, EMT profile and stem cell features in head and neck cancer, Integrated data analysis reveals potential drivers and pathways disrupted by DNA methylation in papillary thyroid carcinomas, Integrated genomic analyses in PDX model reveal a cyclin-dependent kinase inhibitor Palbociclib as a novel candidate drug for nasopharyngeal carcinoma, Novel insights into epigenetic drivers of oropharyngeal squamous cell carcinoma: role of HPV and lifestyle factors, X-chromosome association study reveals genetic susceptibility loci of nasopharyngeal carcinoma, Compared characteristics of current vs. past smokers at the time of diagnosis of a first-time lung or head and neck cancer: a cross-sectional study, Investigating adherence to Australian nutritional care guidelines in patients with head and neck cancer, Thyroid cancer risk in airline cockpit and cabin crew: a meta-analysis, Easily detected signs of perineural tumour spread in head and neck cancer, FDG-PET/CT pitfalls in oncological head and neck imaging, Genome-wide DNA methylation profile identified a unique set of differentially methylated immune genes in oral squamous cell carcinoma patients in India, Multimodality imaging of paragangliomas of the head and neck, The utility of MRI histogram and texture analysis for the prediction of histological diagnosis in head and neck malignancies, 3-weekly or weekly cisplatin concurrently with radiotherapy for patients with squamous cell carcinoma of the head and neck – a multicentre, retrospective analysis, A plea to provide best evidence in trials under sample-size restrictions: the example of pioglitazone to resolve leukoplakia and erythroplakia in Fanconi anemia patients, Carbonyl reductase 1 is a new target to improve the effect of radiotherapy on head and neck squamous cell carcinoma, Phase I/II trial of Durvalumab plus Tremelimumab and stereotactic body radiotherapy for metastatic head and neck carcinoma, Postoperative (chemo) radiation in patients with squamous cell cancers of the head and neck – clinical results from the cohort of the clinical cooperation group “Personalized Radiotherapy in Head and Neck Cancer”, Serum proteomic-based analysis identifying autoantibodies against PRDX2 and PRDX3 as potential diagnostic biomarkers in nasopharyngeal carcinoma, Targeting phosphoinositide 3-kinase (PI3K) in head and neck squamous cell carcinoma (HNSCC), Ultrasound-guided percutaneous laser ablation for papillary thyroid microcarcinoma: a retrospective analysis of 37 patients, A new molecular mechanism underlying the EGCG-mediated autophagic modulation of AFP in HepG2 cells, Accelerated vs. conventionally fractionated adjuvant radiotherapy in high-risk head and neck cancer: a meta-analysis, Combating head and neck cancer metastases by targeting Src using multifunctional nanoparticle-based saracatinib, Effect of DACH1 on proliferation and invasion of laryngeal squamous cell carcinoma, Histone deacetylase inhibitors suppress aggressiveness of head and neck squamous cell carcinoma via histone acetylation-independent blockade of the EGFR-Arf1 axis, Trans-vaccenic acid inhibits proliferation and induces apoptosis of human nasopharyngeal carcinoma cells via a mitochondrial-mediated apoptosis pathway, Feasibility and acceptability of combining cognitive behavioural therapy techniques with swallowing therapy in head and neck cancer dysphagia, Improving quality of life through the routine use of the patient concerns inventory for head and neck cancer patients: a cluster preference randomized controlled trial, Progressive resistance training in cachectic head and neck cancer patients undergoing radiotherapy: a randomized controlled pilot feasibility trial, Time abides long enough for those who make use of it, View the latest posts on the On Medicine homepage. For more information about oral cancer, and its diagnosis and treatment, visit the following organizations’ websites. Head and neck cancer accounts for 5–10% of all cancers in the United States and Europe.

The Oral Cancer Foundation plans walks in cities around the country in which funds raised go toward combating this disease through research, awareness campaigns, and free oral cancer screenings. While most commonly associated with cervical cancer, human papillomavirus (HPV) infection is also associated with head and neck cancer—and incidence rates are rising among certain groups. As in past years, free screenings will occur all over the US and abroad throughout the year. The premier source of oral health information, the ADA has advocated for the public's health and promoted the art and science of dentistry since 1859. Historically, those at an especially high risk of developing oral cancer have been heavy drinkers and smokers older than age 50, but today the cancer also is occurring more frequently in younger, nonsmoking people. The Oral Cancer Foundation The Oral Cancer Foundation is a national public service, IRS registered 501(c)3 head and neck cancer charity, designed to reduce suffering and save lives through prevention, education, research funding, advocacy, and patient support activities. April 7-14, 2019 is Head and Neck Cancer Awareness Week. Oral, head, and neck cancer (OHNC) is rare, and those who don’t have it often know nothing about it. It accounts for about 5 percent of all new cancer cases in the United States. The majority of screenings will take place during Oral, Head and Neck Cancer Awareness Week®, April 13-19, 2020. Why should we care? Download Our 8-page COVID-19 Survival Guide, Support for People With Oral and Head and Neck Cancer, National Oral, Head, and Neck Cancer Awareness Month, Centers for Disease Control and Prevention, Find out what events are coming up on their website, standard for trustworthy health information.